Skip to main content
Vicarious Surgical Inc. logo

Vicarious Surgical Inc. — Investor Relations & Filings

Ticker · RBOT ISIN · US92561V1098 US Manufacturing
Filings indexed 660 across all filing types
Latest filing 2021-07-26 Merger & Acquisition
Country US United States of America
Listing US RBOT

About Vicarious Surgical Inc.

https://www.vicarioussurgical.com/

Vicarious Surgical Inc. is a medical robotics company developing a next-generation surgical platform for minimally invasive procedures. Its core product, the Vicarious Surgical System, is designed to operate through a single port, requiring an incision as small as 1.5 cm for a camera and two robotic instruments to access the abdomen. The system's proprietary technology features human-like robotic arms engineered to replicate the full range of a surgeon's upper body movements, providing enhanced dexterity and control. A key design feature is that all robotic motion occurs inside the patient, which aims to maximize maneuverability and reduce the risk of external collisions. The platform provides surgeons with an immersive 3D, 360-degree view from inside the patient, creating a sense of being transported to the surgical site. The system consists of a Patient Cart and a Surgeon Console, from which the surgeon operates the robot to increase surgical efficiency and precision.

Recent filings

Filing Released Lang Actions
425 Filing
Merger & Acquisition Classification · 95% confidence The document is filed pursuant to Rule 425 under the Securities Act of 1933 and Rule 14a-12 under the Securities Exchange Act of 1934, indicating it is related to a merger or acquisition communication. It includes a transcript of an interview with the CEO of Vicarious Surgical Inc. discussing the SPAC transaction and business combination with D8 Holdings Corp. The text also references a Form S-4 registration statement, proxy statements, and solicitation of shareholder votes for the proposed business combination. These elements are typical of merger communications filed under Rule 425, which are part of the merger and acquisition process but are not the merger proxy statement itself. Therefore, the document fits the category of Merger & Acquisition filings (MA).
2021-07-26 English
425 Filing
Merger & Acquisition Classification · 95% confidence The document is a transcript of an interview with the CEO of Vicarious Surgical Inc. at a conference, discussing the company's technology, regulatory pathway, and partnership with D8 Holdings Corp. It is filed pursuant to Rule 425 under the Securities Act of 1933 and Rule 14a-12 under the Securities Exchange Act of 1934, which are rules related to merger communications and proxy solicitation. The presence of Rule 425 filing and the mention of a proposed business combination indicate this is a merger-related communication. The document is a transcript of an interview, not a financial report, earnings release, or regulatory filing. Therefore, the most appropriate classification is Merger & Acquisition (MA), which covers merger communications such as Form 425 filings.
2021-07-26 English
425 Filing
Merger & Acquisition Classification · 95% confidence The document is a transcript of an interview with the CEO of Vicarious Surgical Inc., discussing the company's progress, SPAC merger, regulatory plans, executive team, and business strategy. It is filed pursuant to Rule 425 under the Securities Act of 1933 and Rule 14a-12 under the Securities Exchange Act of 1934, which are typically used for merger communications and related disclosures. The content is a detailed communication related to a merger transaction (SPAC merger) and includes extensive discussion about the company's business and financing strategy. This aligns with the category for merger communications filings, specifically Rule 425 filings, which are part of the Merger & Acquisition (MA) category. The document is not a financial report, earnings release, or regulatory filing in the general sense, but a merger-related communication. Therefore, the appropriate classification is Merger & Acquisition (MA).
2021-07-21 English
D8 HOLDINGS CORP.
Major Shareholding Notification
2021-07-16 English
M&A Activity 2021
M&A Activity Classification · 95% confidence The document is a detailed response letter from a company to the SEC staff regarding comments on a Registration Statement on Form S-4. The Form S-4 is used for business combination transactions such as mergers or acquisitions involving securities. The text discusses revisions to disclosures in the Registration Statement, including ownership, valuation, risk factors, and other regulatory compliance matters related to a business combination. There is no indication that this is the business combination proxy statement itself, but rather a comment letter response. The document is not an Annual Report, Earnings Release, or other financial report. It is clearly related to a merger transaction and the regulatory review process of the Form S-4 filing. Therefore, the most appropriate classification is "M&A Activity (TAR)" which covers announcements and documents related to merger proposals or takeover bids, including SEC comment letter responses on Form S-4 filings.
2021-07-15 English
REGISTRATION STATEMENT
Capital/Financing Update Classification · 95% confidence The document is a Form S-4/A Registration Statement filed with the SEC, dated July 15, 2021. It relates to a business combination involving D8 Holdings Corp. and Vicarious Surgical Inc., including a merger, domestication, and issuance of securities. The text includes detailed information about the securities to be registered, the merger agreement, and the proxy statement/prospectus for an extraordinary general meeting. This type of filing is a registration statement for securities offerings in connection with a merger or business combination, which is a capital markets and financing activity. It is not an annual report, earnings release, or other financial report. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed substantive information about the offering and merger, not just an announcement or certification, supporting a high confidence level.
2021-07-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.